Viewing Study NCT00037869


Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2026-02-03 @ 4:29 AM
Study NCT ID: NCT00037869
Status: COMPLETED
Last Update Posted: 2018-10-31
First Post: 2002-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Tumors View
None Metastases, Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic neuroendocrine tumors View